FindMyRecallSubscribe
Class I: serious health riskOngoing

Exela Pharma Sciences Elcys Recall

ELCYS (cysteine hydrochloride injection), USP, 500 mg/10mL (50 mg/mL), 10x10 mL Single…

Exela Pharma Sciences LLC · Lenoir, NC

Risk level
Class I
Reported by FDA
Nov 29, 2023
Recall ID
D-0118-2024
Check your lot numberHow we source this data

Summary

Exela Pharma Sciences recalled Elcys starting Oct 18, 2023. The FDA classified it as Class I (serious health risk) and published enforcement report D-0118-2024 on Nov 29, 2023. Reason: Presence of Particulate Matter: Silicone. Status: Ongoing.

Why it was recalled

Presence of Particulate Matter: Silicone

Product description

ELCYS (cysteine hydrochloride injection), USP, 500 mg/10mL (50 mg/mL), 10x10 mL Single Dose Sterile Vials, For Intravenous Infusion Only, Rx Only, Manufactured and Distributed by Exela Pharma Sciences, LLC, Lenoir, NC 28645, (Vial: NDC 51754-1007-1; Carton: 51754-1007-3).

Lot numbers, UPCs & expiration codes

Lot # 10000798, Expiration Date 03/31/2025

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0118-2024
Classification
Class I
Status
Ongoing
Recall initiated
Oct 18, 2023
FDA report date
Nov 29, 2023
Quantity
38,200 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Exela Pharma Sciences LLC

Original FDA data

Every field from FDA enforcement report D-0118-2024, exactly as published.

Show all FDA fields
City
Lenoir
State
NC
Status
Ongoing
Country
United States
Event ID
93265
Address
1245 Blowing Rock Blvd
Code information
Lot # 10000798, Expiration Date 03/31/2025
Postal code
28645-3618
Report date
Nov 29, 2023
Product type
Drugs
Recall number
D-0118-2024
Classification
Class I
Recalling firm
Exela Pharma Sciences LLC
Product quantity
38,200 vials
Reason for recall
Presence of Particulate Matter: Silicone
Voluntary / mandated
Voluntary: Firm initiated
Product description
ELCYS (cysteine hydrochloride injection), USP, 500 mg/10mL (50 mg/mL), 10x10 mL Single Dose Sterile Vials, For Intravenous Infusion Only, Rx Only, Manufactured and Distributed by Exela Pharma Sciences, LLC, Lenoir, NC 28645, (Vial: NDC 51754-1007-1; Carton: 51754-1007-3).
Distribution pattern
Nationwide
Recall initiation date
Oct 18, 2023
Initial firm notification
Letter
Center classification date
Nov 22, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0118-2024, published Nov 29, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls